RHO and colorectal carcinoma: In sum, we reveal a novel TRIM65–GAP–Rho regulatory axis that modulates the actin cytoskeleton and the migration behavior of CRC cells, and the TRIM65–ARHGAP35 interaction might be a valuable therapeutic target in CRC.